Leptomeningeal Disease clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for

  • Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease

    Sorry, not yet accepting patients

    Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this population and how treatments guide care management decisions.

    San Francisco, California

Our lead scientists for Leptomeningeal Disease research studies include .

Last updated: